Natural regulatory T cells are resistant to calcium release-activated calcium (CRAC/ORAI) channel inhibition

International Immunology

Volumn 25, Issue 9, 2013, Pages 497-506

  Jin, Shu ^a   Chin, Jayne ^a   Kitson, Christopher ^a   Woods, John ^a   Majmudar, Rupal ^b   Carvajal, Valerie ^b   Allard, John ^b   DeMartino, Julie ^a   Narula, Satwant ^a   Thomas Karyat, Dori A ^a  

^a Inflammation Discovery Therapeutic Area   (United States)

^b Translational Research Sciences   (United States)

Author keywords

Cyclosporin A; FoxP3; ORAI channels; Tregs

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CYCLOSPORIN A; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CYCLOSPORIN A; FOXP3; ORAI CHANNELS; TREGS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, REGULATORY;

EID: 84882947835     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt013     Document Type: Article

References (41)

1. De Serres, S. A., Sayegh, M. H. and Najafian, N. 2009. Immunosuppressive drugs and Tregs: a critical evaluation! Clin. J. Am. Soc. Nephrol. 4:1661.
2. Oh-hora, M. 2009. Calcium signaling in the development and function of T-lineage cells. Immunol. Rev. 231:210.
3. San Segundo, D., Ruiz, J. C. Fernández-Fresnedo, G. et al. 2006. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. Transplant. Proc. 38:2391.
4. Lim, D. G., Koo, S. K., Park, Y. H., et al. 2010. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Transplantation 89:928.
5. Chen, W., Jin, W., Hardegen, N., et al. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
6. Schmidt, A., Oberle, N. and Krammer, P. H. 2012. Molecular mechanisms of treg-mediated T cell suppression. Front. Immunol. 3:51.
7. Wang, H., Zhao, L., Sun Z., et al. 2006. A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 82:1484.
8. Josefowicz, S. Z., Lu, L. F., and Rudensky, A. Y. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531.
9. Thornton, A. M., Korty, P. E., Tran, D. Q., et al. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184:3433.
10. Bilate, A. M., and Lafaille, J. J. 2012. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30:733.
11. Lan, Q., Fan, H., Quesniaux, V., et al. 2012. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J. Mol. Cell. Biol. 4:22.
12. Curotto de Lafaille, M. A., and Lafaille, J. J. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity 30:626.
13. Feske, S. 2007. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7:690.
14. Feske, S., Skolnik, E. Y., and Prakriya, M. 2012. Ion channels and transporters in lymphocyte function and immunity. Nat. Rev. Immunol. 12:532.
15. Hogan, P. G., Lewis, R. S., and Rao, A. 2010. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28:491.
16. Li, H., Rao, A., and Hogan, P. G. 2011. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 21:91.
17. Gwack, Y., et al. 2007. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 42:145.
18. Feske, S. 2009. ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. Immunol. Rev. 231:189.
19. Oh-hora, M., and Rao, A. 2009. The calcium/NFAT pathway: role in development and function of regulatory T cells. Microbes Infect. 11:612.
20. Mantel, P. Y., Ouaked, N., Rückert, B., et al. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176:3593.
21. Wu, Y., Borde, M., Heissmeyer, V., et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126:375.
22. Hu, H., Djuretic, I., Sundrud, M. S., Rao, A., et al. 2007. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol. 28:329.
23. Demirkiran, A., Hendrikx, T. K., Baan, C. C., van der Laan, L. J., et al. 2008. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 85:783.
24. Vig, M., DeHaven, W. I., Bird, G. S., et al. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9:89.
25. Gwack, Y., Srikanth, S., Oh-Hora, M., et al. 2008. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol. Cell Biol. 28:5209.
26. Singh, N., Yamamoto, M., Takami, M., et al. 2010. CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J. Immunol. 184:94.
27. Wahl, S. M., and Chen, W. 2005. Transforming growth factor-betainduced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res. Ther. 7:62.
28. Hippen, K. L., Merkel, S. C., Schirm, D. K., et al. 2011. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transplant. 11:1148.
29. Ishikawa, J., Ohga, K., Yoshino, T., et al. 2003. A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes. J. Immunol. 170:4441.
30. Yoshino, T., Ishikawa, J., Ohga, K., et al. 2007. YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. Eur. J. Pharmacol. 560:225.
31. Gwack, Y., Srikanth, S., Feske, S., et al. 2007. Biochemical and functional characterization of Orai proteins. J. Biol. Chem. 282:16232.
32. Ohga, K., Takezawa, R., Yoshino, T., et al. 2008. The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Pulm. Pharmacol. Ther. 21:360.
33. Burchill, M. A. Yang, J., Vang, K. B., Farrar, M. A., et al. 2007. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 114:1.
34. Flanagan, M. E., Blumenkopf, T. A., Brissette, W. H., et al. 2010. Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection. J. Med. Chem. 53:8468.
35. Chen, G., Panicker, S., Lau, K. Y., et al. 2013. Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Mol. Immunol. 54:355.
36. Getnet, D., Grosso, J. F., Goldberg, M. V., et al. 2010. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol. Immunol. 47:1595.
37. Rudra, D., deRoos, P., Chaudhry, A., et al. 2012. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 13:1010.
38. Schmidt, A., Oberle, N., Weiss, E. M., et al. 2011. Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-kappaB, and NFAT signaling in conventional T cells. Sci. Signal. 4:ra90.
39. Gao, W., Lu, Y., El Essawy, B., et al. 2007. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigenspecific regulatory T cells. Am. J. Transplant. 7:1722.
40. Lebranchu, Y., Snanoudj, R., Toupance, O., et al. 2012. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study. Am. J. Transplant. 12:1801.
41. Zuber, J., Brodin-Sartorius, A., Thervet, E., Legendre, C., et al. 2007. Cyclosporine abrogates de novo generation of Tregs independently of IL-2. Am. J. Transplant. 7:2645; author reply 2646.